Pulmonx Cash Flow from Operating Activities 2019-2024 | LUNG
Pulmonx cash flow from operating activities from 2019 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Pulmonx Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $-32 |
| 2023 | $-38 |
| 2022 | $-45 |
| 2021 | $-41 |
| 2020 | $-31 |
| 2019 | $-21 |
| 2018 | $-18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.268B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.685B | 52.05 |
| Tempus AI (TEM) | United States | $8.308B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.565B | 105.54 |
| Inspire Medical Systems (INSP) | United States | $4.740B | 92.07 |
| IRhythm Technologies (IRTC) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.706B | 204.09 |
| Enovis (ENOV) | United States | $2.177B | 13.50 |
| Clover Health Investments (CLOV) | United States | $1.834B | 0.00 |
| Omnicell (OMCL) | United States | $1.635B | 35.31 |
| Azenta (AZTA) | United States | $1.583B | 73.70 |
| Phreesia (PHR) | United States | $1.502B | 0.00 |
| Schrodinger (SDGR) | United States | $1.442B | 0.00 |
| 10x Genomics (TXG) | United States | $1.068B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.554B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.522B | 0.00 |
| Veradigm (MDRX) | United States | $0.469B | 0.00 |
| Talkspace (TALK) | United States | $0.431B | 256.00 |
| TruBridge (TBRG) | United States | $0.411B | 0.00 |
| Standard BioTools (LAB) | United States | $0.409B | 0.00 |
| Claritev (CTEV) | United States | $0.334B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.318B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.238B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.221B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| CareCloud (CCLD) | United States | $0.059B | 2.53 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |